Filtered By:
Specialty: Biomedical Science
Condition: Autoimmune Disease
This page shows you your search results in order of date.
Order by Relevance | Date
Total 159 results found since Jan 2013.
Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination
CONCLUSION: The results of the survey of patients with ARD revealed that patient-reported AEs and underlying disease flares after receiving the COVID-19 vaccine were significantly higher than those after the influenza vaccine.PMID:37582497 | DOI:10.3346/jkms.2023.38.e247
Source: Journal of Korean Medical Science - August 15, 2023 Category: Biomedical Science Authors: Ji-Won Kim Ju-Yang Jung Chang-Hee Suh Young-Min Ye Hyoun-Ah Kim Source Type: research
Celiac disease and COVID-19 in adults: A systematic review
ConclusionThe risk of acquiring COVID-19 in CD patients is lower than in the general population. Females were more likely to be infected by COVID-19, and the most common comorbidity in infected patients was a chronic lower respiratory disease; around 10% of infected patients needed hospitalization, GFD adherence, and HR-QOL was more or less the same before and during the pandemic, depression, anxiety, and stress levels of patients varied among studies. Patients had more difficulties accessing GFPs based on limited data.
Source: PLoS One - May 16, 2023 Category: Biomedical Science Authors: Parsa Amirian Source Type: research
Nosocomial Infections in COVID-19 Patients Treated with Immunomodulators: A Narrative Review
Front Biosci (Schol Ed). 2022 Sep 26;14(4):26. doi: 10.31083/j.fbs1404026.ABSTRACTNosocomial infections pose an imminent challenge to hospitalized Coronavirus disease-19 (COVID-19) patients due to complex interplay of dysregulated immune response combined with immunomodulator therapy. In the pre-pandemic era, immunomodulatory therapy has shown benefit in certain autoimmune conditions with untamed inflammatory response. Efforts to recapitulate these immunomodulatory effects in COVID-19 patients has gained impetus and were followed by NIH COVID-19 expert panel recommendations. The current NIH guideline recommends interleukin...
Source: Frontiers in Bioscience - Scholar - December 28, 2022 Category: Biomedical Science Authors: Chidambaram Ramasamy Gayatri Narayan Ajay Kumar Mishra Kevin John John Amos Lal Source Type: research
